We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals
ARMP

21 hedge funds and large institutions have $2.79M invested in Armata Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

0.08% more ownership

Funds ownership: 4.6% → 4.69% (+0.08%)

0% more funds holding

Funds holding: 21 → 21 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

17% less capital invested

Capital invested by funds: $3.37M → $2.79M (-$574K)

Holders
21
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WS
Wedbush Securities
California
+$35.5K
2
Renaissance Technologies
Renaissance Technologies
New York
+$31K
3
TRCT
Tower Research Capital (TRC)
New York
+$609
4
Osaic Holdings
Osaic Holdings
Arizona
+$468
5
SSB
Sandy Spring Bank
Maryland
+$352

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$5.88K
2
BlackRock
BlackRock
New York
-$3.32K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
1
Bank of America
North Carolina
$2.02M – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$299K +$31K +8,821 +10%
BlackRock
3
BlackRock
New York
$131K -$3.32K -944 -2%
Edgewood Management
4
Edgewood Management
Connecticut
$128K – – –
Stifel Financial
5
Stifel Financial
Missouri
$63K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$48K – – –
SWM
7
SeaCrest Wealth Management
New York
$40K – – –
WS
8
Wedbush Securities
California
$32K +$35.5K +10,103 New
Bank of Montreal
9
Bank of Montreal
Ontario, Canada
$8K – – –
TRCT
10
Tower Research Capital (TRC)
New York
$7K +$609 +173 +8%
Morgan Stanley
11
Morgan Stanley
New York
$6K – – –
Northwestern Mutual Wealth Management
12
Northwestern Mutual Wealth Management
Wisconsin
$2K – – –
SSB
13
Sandy Spring Bank
Maryland
$2K +$352 +100 +17%
GWM
14
Geneos Wealth Management
Colorado
$1K – – –
TWA
15
TCI Wealth Advisors
Arizona
$1K – – –
Osaic Holdings
16
Osaic Holdings
Arizona
$1K +$468 +133 +79%
UBS Group
17
UBS Group
Switzerland
– -$5.88K -1,671 -100%
Wells Fargo
18
Wells Fargo
California
– +$46 +13 +45%

ARMP Hedge Fund Activity: Q3 2020 in Review

21 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q3 2020, worth a combined $2.79M — down 17% from $3.37M a quarter earlier.

Fund positioning in ARMP was balanced in Q3 2020: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 2 trimmed.

The largest buyer was Wedbush Securities, opening a new position worth an estimated $35.5K. The largest seller was UBS Group, cutting an estimated $5.88K.

  • 21 institutional investors held Armata Pharmaceuticals (ARMP) as of Q3 2020, unchanged from Q2 2020.
  • Funds reported $2.79M of Armata Pharmaceuticals stock for Q3 2020, down 17% quarter-over-quarter.
  • 1 fund opened new Armata Pharmaceuticals positions in Q3 2020 and 1 closed out, a net change of 0 holders.
  • The largest Armata Pharmaceuticals buyer in Q3 2020 was Wedbush Securities, an estimated $35.5K added.
  • The largest Armata Pharmaceuticals seller in Q3 2020 was UBS Group, an estimated $5.88K sold.

Based on aggregated 13F filings for Q3 2020.